富祥藥業(300497.SZ):子公司取得土地使用權證書
格隆匯 8 月 17日丨富祥藥業(300497.SZ)公佈,公司於2020年7月26日披露了《關於全資子公司競拍取得土地使用權的公告》,公司全資子公司景德鎮富祥生命科技有限公司(“景德鎮富祥”)分別以人民幣約1.22億元人民幣、568.47萬元競得DHA2020045、DHA2020046地塊的土地使用權,並與景德鎮市國土資源交易中心簽訂了《國有建設用地使用權成交確認書》;於2020年8月4日披露了《關於全資子公司簽署國有土地出讓合同的公告》,景德鎮富祥與景德鎮市自然資源和規劃局分別簽署了合同編號為36202005000021和36202005000022的《國有建設用地使用權出讓合同》。
近日,公司已經完成上述土地使用權的權屬登記手續,並取得景德鎮市不動產登記局出具的《中華人民共和國不動產權證》。
此次取得土地使用權證書後,可以滿足未來公司發展戰略對經營場地的需求,有利於公司的長遠發展,有利於提升公司的持續發展能力和綜合競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.